An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board...
Do you support it?
Want to know if it passes?
We'll email you when SB 190 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 190.
You're tracking SB 190
We'll email you the moment it moves.
SB 190 — An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
Last action — Referred to BANKING AND INSURANCE, Jan. 29, 2025
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced January 29, 2025. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
8 sponsors
1 primary, 7 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (7 D · 1 R) — cross-party backing.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Pharmaceutical Transparency
Bill Text
- Printer's No. 0140 View text Current
Action History
-
Referred to BANKING AND INSURANCE, Jan. 29, 2025
Sponsors
- Sharif Street · Primary
- Timothy P. Kearney · Cosponsor
- Vincent J. Hughes · Cosponsor
- Jay Costa · Cosponsor
- John I. Kane · Cosponsor
- Judith L. Schwank · Cosponsor
- Daniel Laughlin · Cosponsor
- Maria Collett · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 7 co-sponsors · 245 not signed on
Sponsors (1)
- Sharif Street Democratic
Co-sponsors (7)
- Timothy P. Kearney Democratic
- Vincent J. Hughes Democratic
- Jay Costa Democratic
- John I. Kane Democratic
- Judith L. Schwank Democratic
- Daniel Laughlin Republican
- Maria Collett Democratic
Not signed on (245)
245 members have not signed on to this bill.
Show all 245 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 190 do?
- Pharmaceutical Transparency
- Who sponsors SB 190?
- SB 190 is sponsored by Sharif Street (Democratic), Timothy P. Kearney (Democratic), Vincent J. Hughes (Democratic), Jay Costa (Democratic), John I. Kane (Democratic), Judith L. Schwank (Democratic), Daniel Laughlin (Republican), and Maria Collett (Democratic).
- What is the current status of SB 190?
- This bill is in committee in the Senate. Introduced January 29, 2025. It must pass committee before a floor vote.
- Where can I track SB 190?
- Track SB 190 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 190
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 190
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →